Applicant, as named in the Orange Book

Amphastar Pharms Inc

Next listed expiry: Baqsimi on 23 Sep 2039. 1 products with live protection, 2 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Baqsimi glucagon	glucagon	210134	23 Sep 2039	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (2)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Cortrosyn cosyntropin	cosyntropin	016750	open now	no listed protection
Rextovy naloxone hydrochloride	naloxone hydrochloride	208969	open now	no listed protection